{"id":415921,"date":"2021-01-15T13:33:27","date_gmt":"2021-01-15T18:33:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=415921"},"modified":"2021-01-15T13:33:27","modified_gmt":"2021-01-15T18:33:27","slug":"emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/","title":{"rendered":"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th"},"content":{"rendered":"<div class=\"mw_release\">\n<p>San Diego, Calif, Jan.  15, 2021  (GLOBE NEWSWIRE) &#8212; Emerald Bioscience, Inc. (OTCQB:\u00a0EMBI) (\u201cEMBI\u201d or\u00a0the \u201cCompany\u201d), a biopharmaceutical company focused on developing\u00a0proprietary, synthetic\u00a0cannabinoid-derived molecules\u00a0to treat glaucoma and other diseases with significant unmet need,\u00a0has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. The Company\u00a0will trade under its\u00a0new ticker symbol, \u201cSKYE,\u201d\u00a0on the OTC\u00a0effective at\u00a0market open on Tuesday, January 19, 2021. <\/p>\n<p>\n        <strong>About\u00a0Emerald\u00a0Bioscience, Inc.\u00a0<\/strong>\u00a0<\/p>\n<p>Emerald\u00a0Bioscience\u00a0Inc.\u00a0is a biopharmaceutical company developing\u00a0differentiated,\u00a0proprietary cannabinoid-derived molecules\u00a0to treat\u00a0diseases with significant unmet needs.\u00a0The Company\u2019s lead\u00a0molecule, in preclinical studies, has\u00a0demonstrated potential\u00a0as\u00a0a new class\u00a0of\u00a0therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs.\u00a0For more information,\u00a0please\u00a0visit <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iYt3oW6jrG6w2mjX-bBhS5aTuUwyigiwUrG2GdzWkKMntYeoSUq6UqrOsdMJR0h_TYYlqSBwJtUCqPcfsmwkY2HHU_dgR8uRLuqVEMSI0Z4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.emeraldbio.life<\/a><\/u>.<\/p>\n<p align=\"justify\">\n        <strong>CONTACT<\/strong>\u00a0<br \/>Karam Takhar\u00a0\u00a0<br \/>VP,\u00a0Corporate Development &amp; Investor Relations\u00a0\u00a0<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Me878Ba3FKVG8OfQ61BIRwokydDrLuqOTcsxBsObMC878mC108l4rx5YzP-5CWhWKL75WLpcMc0kP32KWwuD_DyST5Wo1BVc_aQwCBB0ILk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>ir@emeraldbio.life<\/u><\/a> \u00a0<br \/>Phone: +1-949-336-3437\u00a0<\/p>\n<p align=\"justify\">\n        <strong>FORWARD LOOKING STATEMENTS\u00a0<\/strong>\u00a0<\/p>\n<p align=\"justify\">This press release contains forward-looking statements, including statements regarding our product development, business strategy,\u00a0relocation of corporate headquarters, timing of clinical trials and commercialization of cannabinoid-based therapeutics. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management\u2019s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including \u201canticipated,\u201d \u201ccontemplates,\u201d \u201cgoal,\u201d \u201cfocus,\u201d \u201caims,\u201d \u201cintends,\u201d \u201cbelieves,\u201d \u201ccan,\u201d \u201ccould,\u201d \u201cchallenge,\u201d \u201cpredictable,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cmay\u201d or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Emerald may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of Emerald\u2019 most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, Emerald disclaims any intent or obligation to update these forward-looking statements.\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f5d7a422-39b2-47cc-9288-38f715dcdb1a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) &#8212; Emerald Bioscience, Inc. (OTCQB:\u00a0EMBI) (\u201cEMBI\u201d or\u00a0the \u201cCompany\u201d), a biopharmaceutical company focused on developing\u00a0proprietary, synthetic\u00a0cannabinoid-derived molecules\u00a0to treat glaucoma and other diseases with significant unmet need,\u00a0has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. The Company\u00a0will trade under its\u00a0new ticker symbol, \u201cSKYE,\u201d\u00a0on the OTC\u00a0effective at\u00a0market open on Tuesday, January 19, 2021. About\u00a0Emerald\u00a0Bioscience, Inc.\u00a0\u00a0 Emerald\u00a0Bioscience\u00a0Inc.\u00a0is a biopharmaceutical company developing\u00a0differentiated,\u00a0proprietary cannabinoid-derived molecules\u00a0to treat\u00a0diseases with significant unmet needs.\u00a0The Company\u2019s lead\u00a0molecule, in preclinical studies, has\u00a0demonstrated potential\u00a0as\u00a0a new class\u00a0of\u00a0therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs.\u00a0For more information,\u00a0please\u00a0visit www.emeraldbio.life. CONTACT\u00a0Karam Takhar\u00a0\u00a0VP,\u00a0Corporate Development &amp; Investor Relations\u00a0\u00a0Email: ir@emeraldbio.life \u00a0Phone: +1-949-336-3437\u00a0 FORWARD LOOKING STATEMENTS\u00a0\u00a0 This press &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-415921","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) &#8212; Emerald Bioscience, Inc. (OTCQB:\u00a0EMBI) (\u201cEMBI\u201d or\u00a0the \u201cCompany\u201d), a biopharmaceutical company focused on developing\u00a0proprietary, synthetic\u00a0cannabinoid-derived molecules\u00a0to treat glaucoma and other diseases with significant unmet need,\u00a0has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. The Company\u00a0will trade under its\u00a0new ticker symbol, \u201cSKYE,\u201d\u00a0on the OTC\u00a0effective at\u00a0market open on Tuesday, January 19, 2021. About\u00a0Emerald\u00a0Bioscience, Inc.\u00a0\u00a0 Emerald\u00a0Bioscience\u00a0Inc.\u00a0is a biopharmaceutical company developing\u00a0differentiated,\u00a0proprietary cannabinoid-derived molecules\u00a0to treat\u00a0diseases with significant unmet needs.\u00a0The Company\u2019s lead\u00a0molecule, in preclinical studies, has\u00a0demonstrated potential\u00a0as\u00a0a new class\u00a0of\u00a0therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs.\u00a0For more information,\u00a0please\u00a0visit www.emeraldbio.life. CONTACT\u00a0Karam Takhar\u00a0\u00a0VP,\u00a0Corporate Development &amp; Investor Relations\u00a0\u00a0Email: ir@emeraldbio.life \u00a0Phone: +1-949-336-3437\u00a0 FORWARD LOOKING STATEMENTS\u00a0\u00a0 This press &hellip; Continue reading &quot;Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-15T18:33:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th\",\"datePublished\":\"2021-01-15T18:33:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/\"},\"wordCount\":430,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/\",\"name\":\"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==\",\"datePublished\":\"2021-01-15T18:33:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/","og_locale":"en_US","og_type":"article","og_title":"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th - Market Newsdesk","og_description":"San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) &#8212; Emerald Bioscience, Inc. (OTCQB:\u00a0EMBI) (\u201cEMBI\u201d or\u00a0the \u201cCompany\u201d), a biopharmaceutical company focused on developing\u00a0proprietary, synthetic\u00a0cannabinoid-derived molecules\u00a0to treat glaucoma and other diseases with significant unmet need,\u00a0has changed its name from Emerald Bioscience, Inc. to Skye Bioscience, Inc. The Company\u00a0will trade under its\u00a0new ticker symbol, \u201cSKYE,\u201d\u00a0on the OTC\u00a0effective at\u00a0market open on Tuesday, January 19, 2021. About\u00a0Emerald\u00a0Bioscience, Inc.\u00a0\u00a0 Emerald\u00a0Bioscience\u00a0Inc.\u00a0is a biopharmaceutical company developing\u00a0differentiated,\u00a0proprietary cannabinoid-derived molecules\u00a0to treat\u00a0diseases with significant unmet needs.\u00a0The Company\u2019s lead\u00a0molecule, in preclinical studies, has\u00a0demonstrated potential\u00a0as\u00a0a new class\u00a0of\u00a0therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to currently available drugs.\u00a0For more information,\u00a0please\u00a0visit www.emeraldbio.life. CONTACT\u00a0Karam Takhar\u00a0\u00a0VP,\u00a0Corporate Development &amp; Investor Relations\u00a0\u00a0Email: ir@emeraldbio.life \u00a0Phone: +1-949-336-3437\u00a0 FORWARD LOOKING STATEMENTS\u00a0\u00a0 This press &hellip; Continue reading \"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-15T18:33:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th","datePublished":"2021-01-15T18:33:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/"},"wordCount":430,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/","name":"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==","datePublished":"2021-01-15T18:33:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNjc0NSMzOTIxNDY4IzUwMDA3MDk1Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerald-bioscience-to-change-name-and-trading-symbol-effective-tuesday-january-19th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/415921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=415921"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/415921\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=415921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=415921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=415921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}